LOS ANGELES, June 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ: URGN) for violations of §§10(b) and 20(a) of the Securities Exchange...
Hence then, the article about urgn investors have opportunity to lead urogen pharma ltd securities fraud lawsuit with the schall law firm was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit with the Schall Law Firm )
Also on site :
- ‘Murphy Brown’ Star Jessie Jones Dead at 75
- Spain’s FA condemns Islamophobic chants during game with Egypt
- Teenagers wreak havoc in Clapham during Easter holiday ‘link up’